10/18/2016 | CVLM | LabCorp’s Sequenom wraps tender offer for convertibles due 2017, 2018
|
9/30/2016 | CVLM | LabCorp’s Sequenom takes in tenders for 99.65%, 100% of convertibles
|
9/16/2016 | CVLM | Sequenom begins change-of-control tender offers for 5% convertibles
|
9/7/2016 | CV | LabCorp merger triggers fundamental change under Sequenom convertibles
|
7/27/2016 | DD | Market Commentary: Intelsat bonds trade up on earnings beat; DFC adds as exchange extended; Sequenom converts jump to par
|
7/27/2016 | PP | Market Commentary: Sequenom convertibles jump to par on news of LabCorp takeover; activity in FXCM picks up
|
7/27/2016 | CV | Market Commentary: Sequenom convertibles jump to par on news of LabCorp takeover; activity in FXCM picks up
|
7/27/2016 | CV | Market Commentary: Morning Commentary: Sequenom convertibles jump to par on LabCorp takeover; FXCM eyed
|
1/22/2016 | CV | Market Commentary: Chesapeake Energy preferreds, bonds mixed after dividend suspended to buy back debt
|
8/7/2015 | CV | Market Commentary: Fluidigm ‘comes in’ on the back of disappointing earnings; Iconix drops; Post expands slightly
|
8/7/2015 | CV | Market Commentary: Morning Commentary: Fluidigm ‘comes in’ on the back of disappointing earnings; Post shares pop
|
6/4/2015 | CVLM | Sequenom issues $85 million 5% convertibles due 2018 in exchange
|
7/3/2014 | CV | Market Commentary: NQ Mobile unmoved despite stock plunge; pre-holiday market quiet ahead of early close
|
1/10/2014 | CV | Market Commentary: Alcoa drops outright, slips on hedge after earnings; Home Inns a little better; YRC eyed
|
1/9/2014 | CV | Market Commentary: Midday Commentary: Sequenom jumps outright on patent news; ADM net share settlement, maturity eyed
|
1/9/2014 | CV | Market Commentary: Sequenom jumps outright, adds on hedge; InterMune adds in line; Endeavour up a point
|
9/12/2012 | CV | New Issue: Sequenom prices upsized $110 million five-year convertibles to yield 5%, up 27.5%
|
9/12/2012 | CV | Market Commentary: New Sequenom pops on debut; Sanchez also lifts; Jarden revises talk, prices; Genesee to price
|
9/11/2012 | CV | Market Commentary: Planned Sequenom seen cheap; Jarden, Sanchez Energy launch; D.R. Horton trades in line
|
9/10/2012 | CV | Market Commentary: Titan Machinery drops outright, up on hedge on warning; Intel pulls back; Royal Gold adds
|
9/10/2012 | CV | Sequenom to price $100 million five-year convertibles at 4.75%-5.25%, up 25%-30%
|
1/25/2012 | PP | Sequenom greenshoe fully exercised in $62.04 million public stock sale
|
1/20/2012 | PP | Sequenom sets pricing for $53.95 million public stock sale at $4.15
|
1/19/2012 | PP | Sequenom reports plans to price public offering of common stock
|
11/23/2011 | CVHYPF | Sequenom files $150 million shelf covering stock, preferreds, debt
|
9/21/2010 | CVHYPF | Sequenom files $150 million shelf covering stock, preferreds and debt
|
5/12/2010 | PP | New Issue: Sequenom to pocket $51.61 million in private placement of common stock
|
5/12/2010 | PP | Market Commentary: Chesapeake eyes another $600 million; Sequenom plans issue; Mesoblast gets acquisition funding
|
3/4/2009 | SS | Sequenom adopts rights plan
|
1/27/2009 | SS | Sequenom begins exchange offer for Exact Sciences; set to end March 24
|
9/19/2008 | SS | Millenco-led investors own 4.4% of Sequenom
|
6/23/2008 | CVHY | Sequenom files automatic shelf registration
|
10/29/2007 | SS | Millennium reports 6.5% stake in Sequenom
|
10/26/2007 | PP | New Issue: Sequenom prices $30.45 million private placement of shares
|
10/26/2007 | PP | Market Commentary: Fushi to sell $39 million; Sequenom negotiates $30.45 million; Rocmec Mining wraps C$1.25 million
|
4/26/2007 | PP | Market Commentary: Ireland plans two offerings totaling $13 million; Advanced BioEnergy wraps $10 million placement
|
4/25/2007 | PP | New Issue: Sequenom secures $20 million from direct placement of stock
|
4/25/2007 | PP | Market Commentary: Biotech companies dominate PIPE action; Sequenom secures $20 million from stock sale
|
6/28/2006 | BT | Sequenom regains compliance with Nasdaq listing requirements
|
6/2/2006 | BT | Sequenom implements reverse stock split
|
5/26/2006 | BT | Sequenom receives notice of additional deficiency from Nasdaq
|
4/6/2006 | BT | Sequenom's audit contains 'going concern' qualification
|
4/3/2006 | BTPP | New Issue: Sequenom ups private placement of stock to $33 million
|
3/28/2006 | BT | Market Commentary: Advanced Magnetics gains 7%; Xoma slides; Seattle Genetics deal surfaces; Cephalon dips 2%
|
3/28/2006 | BT | Sequenom Q4 revenue down 28%, predicts 25% increase in 2006 revenue
|
3/28/2006 | PP | Market Commentary: Sequenom's stock drops 9% after $30 million PIPE, earnings report; Calibre raises $6.32 million
|
3/28/2006 | BTPP | New Issue: Sequenom prepares to settle $30 million stock sale
|
3/27/2006 | BT | Sequenom study shows potential for single-platform genetic tests
|
3/21/2006 | BT | Sequenom may be delisted from Nasdaq
|
9/20/2005 | BT | Sequenom gets delisting notice from Nasdaq
|